AUPH AURINIA PHARMACEUTICALS INC
2026Q1 · CUSIP 05156V102 · Sector: Healthcare & Biotech
Neutral · No signal
Holders
257
Δ holders QoQ
-1
Breadth percentile
Top 66%
Whale holders
136
Δ whales
+1
Inst. holding value
$1.1B
New positions
40
Closed positions
41
Price momentum (1Q)
+9.0%
Put / Call
8/8
Breadth history (34 quarters)
Past Lit Events & Aftermath 9 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2025Q3 | Top 14% | -7.0% | +2.6% |
| 2025Q1 | Top 16% | +49.1% | +91.9% |
| 2023Q2 | Top 15% | -16.1% | -38.2% |
| 2022Q2 | Top 9% | -40.1% | -7.0% |
| 2021Q4 | Top 19% | -41.5% | -57.3% |
| 2021Q1 | Top 14% | +17.7% | +142.1% |
| 2020Q1 | Top 8% | -14.7% | -21.2% |
| 2019Q4 | Top 9% | -13.6% | -26.3% |
| 2019Q1 | Top 19% | -10.5% | -22.0% |
Options Sentiment
Put holders
8
QoQ: 0
Call holders
8
QoQ: 0
See methodology →
Fundamentals
PE (TTM)
7.4
EPS (TTM)
$2.17
EPS YoY
+675.0%
Revenue (TTM)
$0.3B
Revenue YoY
+20.6%
Net margin
100.0%
ROE
52.5%
Debt ratio
21.6%
FCF (TTM)
—
Dividend (TTM)
No dividend
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
P/E (TTM) over time
P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden
As of 2026-03-31 · SEC filings (XBRL)
Get the next update
2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.